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1. INTRODUCTION {#agm212006-sec-0005}
===============

Adrenal incidentaloma (AI) is the term given to an adrenal mass discovered incidentally, often during an imaging procedure. The incidence of AI has been rising sharply due to the increased use of radiographic imaging, becoming the leading diagnosis of adrenal disease.[1](#agm212006-bib-0001){ref-type="ref"} Less commonly, AI is also discovered as part of the clinical workup for suspected adrenal disease, e.g. Cushing syndrome.

The current diagnostic criteria of AI are based on the 2016 guidelines set by the American Association of Clinical Endocrinologists (AACE) and the American Association of Endocrine Surgeons (AAES). The adrenal tumor and its malignancy must have been discovered incidentally from an imaging method performed for nonadrenal‐related reasons before any operation.[2](#agm212006-bib-0002){ref-type="ref"}

The detection of AI is 4%‐6%, and the rate of autopsy is about 8% (1%‐32%).[3](#agm212006-bib-0003){ref-type="ref"} According to Bovio\'s research, the detection of AI by high‐resolution computed tomography (CT) scan was about 4.4%.[4](#agm212006-bib-0004){ref-type="ref"} AI increases with aging. The detection of AI in adolescents was only 0.2% compared to 3%‐5% in adults and 7%‐10% in the elderly.[5](#agm212006-bib-0005){ref-type="ref"} Among those who suffered from malignancies, about half of AIs were metastatic.[3](#agm212006-bib-0003){ref-type="ref"}

In this study, we examined 559 AI patients who were diagnosed and treated in Shanghai Changzheng Hospital from January 2002 to December 2016. 41.25% were identified during routine imaging procedures. The diagnosis and treatment process of AI will be discussed using current reports in combination with existing clinical data.

2. MATERIALS AND METHODS {#agm212006-sec-0006}
========================

2.1. Patients {#agm212006-sec-0007}
-------------

A total of 559 AI patients above 65 years of age were received in our hospital from January 2002 to December 2016. The medical records of these patients were collected and collated for the research objects. In all objects, 281 patients underwent surgery and the specimens were sent to the pathological laboratory. The remaining 278 patients went through regular follow‐ups in our hospital without any operation.

All 559 patients were retrospectively analyzed, examining gender, age, race, reasons for seeking medical treatment, laboratory examinations, complications, operation methods, postoperative pathological diagnoses, and follow‐up observations.

2.2. Methods {#agm212006-sec-0008}
------------

Some patients agreed to receive an endocrine function assessment. The following tests could also be conducted to diagnose Cushing syndrome: (i) 24‐hour urinary free cortisol (UFC); (ii) adrenocorticotropic hormone (ACTH); (iii) midnight 1 mg dexamethasone suppression test (1 mg DST); (iv) low‐dose dexamethasone suppression test (LDDST). 1 mg DST and LDDST were used to inhibit the postserum cortisol \>50 nmol/L as a diagnostic point.[3](#agm212006-bib-0003){ref-type="ref"} According to the ACTH level and high‐dose dexamethasone suppression test (HDDST), we can identify ACTH‐dependent and non‐ACTH‐dependent Cushing disease. Primary aldosteronism was screened for using the plasma aldosterone‐to‐renin ratio (ARR; \>30), and was performed at the same time as a vertical decubitus test. Pheochromocytoma was diagnosed by image evaluation and other methods, and the patients were diagnosed by postoperative pathology. The malignant nature was diagnosed by postoperative etiology.

2.3. Statistics {#agm212006-sec-0009}
---------------

SPSS I7.0 software (SPSS Inc., Chicago, IL, USA) was used for data processing. The measurement data were indicated by the mean ± standard deviation (mean ± SD), and *F* test was used for comparison between groups. The count data were expressed in terms of number and proportion (n, %), and chi‐squared test was used for comparison between groups. The difference of *P *\<* *.05 was statistically significant.

3. RESULTS {#agm212006-sec-0010}
==========

3.1. First clinic visit {#agm212006-sec-0011}
-----------------------

Of the 559 patients, about 61.00% (n* *=* *341) were diagnosed during routine medical examinations without having displayed any subjective symptoms or signs. The highest reason for the patients\' first visit was for endocrinology (42.01%), followed by urology (28.65%), general surgery (17.43%), and thoracic surgery (11.90%). The remaining 218 patients showed dysglycemia, thyroid dysfunction, electrolyte disorder or dizziness, fatigue, anorexia, and edema, among other complaints (Table [1](#agm212006-tbl-0001){ref-type="table"}).

###### 

Adrenal incidentaloma patients\' first reason for hospital visit (n* *=* *559)

  Chief complaint[a](#agm212006-note-0001){ref-type="fn"}   N (%)
  --------------------------------------------------------- -------------
  Asymptomatic                                              341 (61.00)
  Lumbago                                                   64 (11.44)
  Urination discomfort                                      25 (4.47)
  Abdominal discomfort                                      26 (4.65)
  Cardiovascular                                            19 (3.39)
  Pulmonary                                                 17 (3.04)
  Others[b](#agm212006-note-0002){ref-type="fn"}            67 (11.99)

Some patients with existing complaints.

Including dysglycemia, thyroid dysfunction, electrolyte disturbances, dizziness, and fatigue.

John Wiley & Sons, Ltd

3.2. Examinations and etiological characteristics {#agm212006-sec-0012}
-------------------------------------------------

All patients underwent adrenal CT or magnetic resonance imaging scanning. 135 cases (24.15%) completed an endocrine function assessment, and 141 cases (25.22%) showed suspicious positive symptoms or signs, including weight gain (25.57%), dysglycemia or insulin resistance (21.28%), and hypertension (30.92%).

Of the 281 patients who received adrenal surgeries, adrenal adenoma is the most common pathological type, accounting for nearly 90%. Functional AI accounts for 15.93% in all AI surgeries, of which 2.32% are pheochromocytoma, 8.38% are aldosterone adenomas, and 4.53% are autonomic cortisol secretion. The etiology in 52 cases with bilateral AIs showed metastatic carcinoma, congenital adrenocortical hyperplasia, adrenal adenoma, lymphoma, infection, bleeding, and so on. The summary and comparison of various pathological types are described in Table [2](#agm212006-tbl-0002){ref-type="table"}.

###### 

The nature of adrenal incidentaloma and comparison of literature reports[3](#agm212006-bib-0003){ref-type="ref"}, [6](#agm212006-bib-0006){ref-type="ref"}, [7](#agm212006-bib-0007){ref-type="ref"}, [8](#agm212006-bib-0008){ref-type="ref"}, [9](#agm212006-bib-0009){ref-type="ref"}, [10](#agm212006-bib-0010){ref-type="ref"}

  All subjects[a](#agm212006-note-0003){ref-type="fn"}    Study (%)   Literature[6](#agm212006-bib-0006){ref-type="ref"}, [7](#agm212006-bib-0007){ref-type="ref"}, [8](#agm212006-bib-0008){ref-type="ref"} (%)   Etiology[a](#agm212006-note-0003){ref-type="fn"}   Study (%)   Literature[3](#agm212006-bib-0003){ref-type="ref"}, [6](#agm212006-bib-0006){ref-type="ref"}, [7](#agm212006-bib-0007){ref-type="ref"}, [8](#agm212006-bib-0008){ref-type="ref"}, [9](#agm212006-bib-0009){ref-type="ref"}, [10](#agm212006-bib-0010){ref-type="ref"} (%)
  ------------------------------------------------------- ----------- -------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------- ----------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Adenoma                                                 79.81       33‐96                                                                                                                                        Nonfunctional benignancy                           88.92       52‐88
  Nonfunctional[b](#agm212006-note-0004){ref-type="fn"}   66.17       71‐84                                                                                                                                        Pheochromocytoma                                   2.32        11‐23
  Primary aldosteronism                                   2.81        1.6‐3.3                                                                                                                                      Autonomic cortisol secretion                       4.53        1.0‐15
  Autonomic cortisol secretion                            11.32       1.0‐29                                                                                                                                       Primary aldosteronism                              8.38        2.0‐7.0
  Pheochromocytoma                                        0.13        1.5‐14                                                                                                                                       Carcinoma                                          3.02        1.2‐12
  Carcinoma                                               4.12        1.2‐11                                                                                                                                       Metastatic carcinoma                               1.66        0‐21
  Metastatic carcinoma                                    5.81        0‐18                                                                                                                                         Others[c](#agm212006-note-0005){ref-type="fn"}     4.26        0‐13

Five hundred fifty‐nine aged patients in our hospital, 281 cases received surgical treatments.

Including adenoma, cyst.

Including adrenal schwannoma, adrenal lymphoma, adrenal teratoma, and ganglion cell neurofibroma.

John Wiley & Sons, Ltd

3.3. FOLLOW‐UP {#agm212006-sec-0013}
--------------

Of the 281 aged patients, 82.21% (n = 231) were frequently followed up postoperatively. 61.49% of cases with preoperative hypokalemia showed the normal level postoperatively. 38.02% of hypertensive patients showed better blood pressure control, while 119 patients still needed oral antihypertensive therapy. In the latest follow‐ups, 51 patients were found to have suffered recurrences (3.55%), with malignancy‐related mortality at 68.62%.

During the observation of the 278 patients who did not undergo any operation, 8.99% revealed new positive endocrine function, and the mean size of adrenal masses increased annually (1.96 ± 0.09 mm, 3.92% per year). 9.12% (n* *=* *51) eventually received invasive or surgical treatments.

4. DISCUSSION {#agm212006-sec-0014}
=============

In recent decades, the incidence of AI has been increasing sharply, while related mortality has had no obvious relative change.[3](#agm212006-bib-0003){ref-type="ref"} We have reasons to believe that the high detection rate is due to the rapid development and wide application of imaging technology.

Adrenal incidentaloma patients usually show no specific signs of hormonal excess or obvious underlying malignancy. In our study, adrenal masses were incidentally discovered in routine examinations of more than half of the patients, who mostly complained of lumbago (11.44%) or urinary symptoms (4.47%; Table [1](#agm212006-tbl-0001){ref-type="table"}). Besides, more than 40% of the patients (n* *=* *141) were found to display suspicious positive symptoms such as high blood pressure, abnormal blood glucose, weight gain, or obesity during the systematic review. The main reason is that abdominal imaging examination is the optimal method for finding chronic diseases in China, and there exists a lack of self‐health awareness as well.[1](#agm212006-bib-0001){ref-type="ref"}, [11](#agm212006-bib-0011){ref-type="ref"}

In addition, the measurement on diagnosis still lacks in certain workups. The majority of patients\' first visits are to the surgical departments, such as urology (28.65%), general surgery (17.43%), and cardiothoracic surgery (11.90%). All patients underwent preoperative imaging to distinguish between benignancy and malignancy, while endocrine function tests are more likely to be overlooked (24.15%).

There are still differences in opinion and controversies about the operation time and style for elderly patients with AI.[1](#agm212006-bib-0001){ref-type="ref"}, [12](#agm212006-bib-0012){ref-type="ref"}, [13](#agm212006-bib-0013){ref-type="ref"}, [14](#agm212006-bib-0014){ref-type="ref"} Basically, we can reach a unified consensus on a few important factors: functional AI,[15](#agm212006-bib-0015){ref-type="ref"} malignancy,[16](#agm212006-bib-0016){ref-type="ref"} life expectancy,[1](#agm212006-bib-0001){ref-type="ref"}, [2](#agm212006-bib-0002){ref-type="ref"} and good physical condition, among others. Most studies suggest that the size of the tumor is one of the most important clinical predictors of benignancy or malignancy of the index.[17](#agm212006-bib-0017){ref-type="ref"} However, our study found no significant differences between benignancy and malignancy (31.16 ± 10.33 mm vs 42.28 ± 23.70 mm, *P *=* *.0327).

Meanwhile, it is particularly important to re‐examine related indicators during the follow‐up. In our study, 24 cases of AI patients who were suspected of autonomic cortisol secretion function during the follow‐up period showed dysglycemia (n* *=* *22), hypertension (n* *=* *8), and other complications. There is no clear evidence by large‐scale study of screening for negative or suspicious positive symptoms in patients without follow‐up assessments of the endocrine function. In particular, more comparative and cohort studies revealed an increasing propendency of subclinical hypercortisolism.[18](#agm212006-bib-0018){ref-type="ref"}, [19](#agm212006-bib-0019){ref-type="ref"}, [20](#agm212006-bib-0020){ref-type="ref"}, [21](#agm212006-bib-0021){ref-type="ref"}, [22](#agm212006-bib-0022){ref-type="ref"}, [23](#agm212006-bib-0023){ref-type="ref"}, [24](#agm212006-bib-0024){ref-type="ref"} A study by Lopez et al. found that the risk of incident diabetes in some patients with nonfunctional, benign AI increases year by year.[25](#agm212006-bib-0025){ref-type="ref"} Considering that there is still a certain misdiagnosis rate in 1 mg DST, it is recommended to complete imaging and endocrine function examinations in at least 5 years of follow‐up, and further set up 1 mg DST cut‐off points that are in line with the Chinese population.

5. CONCLUSION {#agm212006-sec-0015}
=============

Adrenal masses are one of the most common tumors in the elderly Chinese. In the first diagnosis of AI, the nature of the tumor should be determined preoperatively. CT scan is the most valuable image screening method to determine its nature. At the same time, functional properties of endocrine function tests to evaluate AI should exclude autocortisol secretion independent, pheochromocytoma, primary aldosteronism, and other functional lesions. Most benign nonfunctional adenomas do not need further diagnosis and treatment, while treatment of functional ones depends on complications. The adrenal malignancy must be treated by a combined multidisciplinary treatment once an operation is considered, and the follow‐up procedure will be greatly simplified.
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